Published in Am J Gastroenterol on January 01, 1999
Clinical practice. Gastroesophageal reflux disease. N Engl J Med (2008) 3.30
Long-term management of gastroesophageal reflux disease with pantoprazole. Ther Clin Risk Manag (2007) 0.81
Complications of endoscopic biliary sphincterotomy. N Engl J Med (1996) 11.10
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc (2001) 5.94
The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology (1998) 3.60
Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med (2001) 3.28
Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc (1991) 2.17
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med (1999) 2.15
Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst (1990) 2.11
A randomized trial of peroral versus transnasal unsedated endoscopy using an ultrathin videoendoscope. Gastrointest Endosc (1999) 2.09
Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol (1987) 1.97
Reproducibility of ambulatory oesophageal pH monitoring. Gut (1988) 1.97
Cyanoacrylate glue in gastric variceal bleeding. Endoscopy (2002) 1.86
Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther (2011) 1.77
Nonerosive reflux disease--current concepts and dilemmas. Am J Gastroenterol (2001) 1.75
Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut (1987) 1.60
NSAID effect on sporadic colon polyps. Am J Gastroenterol (1993) 1.60
The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med (1999) 1.60
Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther (2007) 1.56
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther (2000) 1.49
Flow cytometry in Barrett's esophagus. What have we learned so far? Dig Dis Sci (1991) 1.48
H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: "for whom the bell tolls". Gastroenterology (1994) 1.42
The difference in colon polyp size before and after removal. Gastrointest Endosc (1996) 1.40
Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects. Aliment Pharmacol Ther (2009) 1.39
Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.34
Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med (1998) 1.30
Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) Study Group. Gastrointest Endosc (1999) 1.27
Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance. Am J Gastroenterol (2000) 1.25
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol (2000) 1.18
Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med (1999) 1.13
Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection. Gastrointest Endosc (2000) 1.12
Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci (1990) 1.12
Laser therapy of Barrett's mucosa. Gastrointest Endosc (1993) 1.11
The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther (2000) 1.10
Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci (1993) 1.08
Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc (2001) 1.06
Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment Pharmacol Ther (1993) 1.05
Bile salts in the esophagus of patients with esophagitis. Scand J Gastroenterol (1988) 1.05
Lack of spontaneous regression of tubular adenomas in two years of follow-up. Am J Gastroenterol (1997) 1.03
Marking and identifying colon lesions. Tattoos, clips, and radiology in imaging the colon. Gastrointest Endosc Clin N Am (1997) 1.00
Randomised clinical trial: MiraLAX vs. Golytely - a controlled study of efficacy and patient tolerability in bowel preparation for colonoscopy. Aliment Pharmacol Ther (2010) 0.96
Effects of fundoplication on the antireflux mechanism. Br J Surg (1987) 0.96
Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis. Arch Intern Med (2000) 0.96
Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg (1982) 0.95
Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa. Cancer Epidemiol Biomarkers Prev (1993) 0.94
Regional, portal hypertension in chronic pancreatitis. Acta Chir Scand (1981) 0.93
Outcome 5 years after 360 degree fundoplication for gastro-oesophageal reflux disease. Br J Surg (1993) 0.92
Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther (2004) 0.92
The time pattern of gastroesophageal reflux. Scand J Gastroenterol (1988) 0.91
Biopsy-negative malignant esophageal stricture: diagnosis by endoscopic ultrasound. Am J Gastroenterol (1998) 0.91
Assessment of oesophageal motor function in patients with dysphagia or chest pain - the Clinical Outcomes Research Initiative experience. Aliment Pharmacol Ther (2003) 0.90
Outlet strut fracture of a Björk-Shiley prosthesis in the mitral position. Am J Cardiol (1984) 0.88
Fingerstick Helicobacter pylori antibody test: better than laboratory serological testing? Am J Gastroenterol (1999) 0.86
Obliteration of esophageal varices by PTP: a follow-up of 43 patients. Ann Surg (1979) 0.86
Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Aliment Pharmacol Ther (2003) 0.85
Total gastrectomy and oesophagojejunostomy with linear stapling devices. Br J Surg (1989) 0.85
Should chromoscopy be part of the "proficient" endoscopist's armamentarium? Gastrointest Endosc (1998) 0.84
Endoscopic balloon dilation for ulcer-induced gastric outlet obstruction. Am J Gastroenterol (1994) 0.84
Peritoneovenous shunting for intractable ascites. Scand J Gastroenterol (1982) 0.83
Two-year incidence of colon adenomas developing after tandem colonoscopy. Am J Gastroenterol (1994) 0.82
Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication. J Clin Gastroenterol (2001) 0.82
Determinants of gastro-oesophageal reflux and their inter-relationships. Br J Surg (1989) 0.82
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. Am J Gastroenterol (1996) 0.82
Emergency and long-term transesophageal sclerotherapy of bleeding esophageal varices. A prospective study of 50 consecutive cases. Scand J Gastroenterol (1982) 0.82
Evaluation of rapid antibody tests for the diagnosis of Helicobacter pylori infection. Am J Gastroenterol (2000) 0.81
Barrett's esophagus: what do we really know about this disease? Am J Gastroenterol (1997) 0.81
Thermal coagulation for nonvariceal bleeding. Endoscopy (2002) 0.81
Selenium status in patients with liver cirrhosis and alcoholism. Br J Nutr (1986) 0.80
Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol (1999) 0.79
Pharmacologic influence on esophageal varices: a preliminary report. Cardiovasc Intervent Radiol (1983) 0.79
A normal initial colonoscopy after age 50 does not predict a polyp-free status for life. Am J Gastroenterol (1994) 0.79
Noninvasive diagnosis of gastroesophageal inflammation using dipyridamole thallium-201 tomography. Am J Gastroenterol (1998) 0.79
Referral patterns and the results of antireflux operations in patients more than sixty years of age. Surg Gynecol Obstet (1991) 0.79
Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C. Aliment Pharmacol Ther (2003) 0.78
Determining the cost of gastroesophageal reflux disease: a decision analytic model. Am J Manag Care (1998) 0.78
The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2002) 0.78
Early biochemical and histological changes in rats exposed to a single injection of thioacetamide. Pharmacol Toxicol (1987) 0.77
Pattern of serum amino acids in patients with liver cirrhosis. Influence of shunt surgery and transesophageal sclerotherapy. Scand J Gastroenterol (1984) 0.77
Relaxation of lower esophageal sphincter and stimulation of gastric secretion and diuresis by antiasthmatic xanthines. Role of adenosine antagonism. Am Rev Respir Dis (1985) 0.77
Subcutaneous transposition of the spleen: a method for treatment of complications in portal hypertension? Ann Surg (1979) 0.76
Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days. Aliment Pharmacol Ther (1999) 0.76
Peroral cholangioscopy with intracorporeal electrohydraulic lithotripsy for choledocholithiasis. Am J Gastroenterol (1992) 0.76
Symptom status and the desire for Helicobacter pylori confirmatory testing after eradication therapy in patients with peptic ulcer disease. Am J Med (1999) 0.76
Cytological screening for Barrett's esophagus using a prototype flexible mesh catheter. Dig Dis Sci (2001) 0.76
Is the only good H. pylori a dead H. pylori? Gastroenterology (1996) 0.76
Recent advances in diagnosis and treatment of acute pancreatitis. West J Med (1989) 0.75
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance. Am J Gastroenterol (1998) 0.75
Nonsteroidal anti-inflammatory drugs, ulcers, and histamine2 blockers. The ostrich phenomenon! Arch Intern Med (1993) 0.75
Medical therapy for gastroesophageal reflux disease. Not all treatments are equal! Arch Intern Med (1991) 0.75
Practice guidelines for treatment of peptic ulcer disease. JAMA (1996) 0.75
"Cure" of Helicobacter pylori and "cure" of peptic ulcer: do they mean the same thing? Am J Gastroenterol (1995) 0.75
'Cure' of Helicobacter pylori. Clinically indicated and economically wise! Arch Intern Med (1995) 0.75
Lysosomal enzymes in plasma, liver and spleen from rats with carbon tetrachloride-induced liver cirrhosis. Enzyme (1985) 0.75
Metabolism of the human serum beta-hexosaminidase isoenzymes in the rat: an in vivo and in vitro study. Enzyme (1986) 0.75
Gastrointestinal bleeding caused by haemosuccus pancreaticus. A presentation of two cases. Acta Chir Scand (1981) 0.75
A comparative study of esophageal varices by endoscopy and percutaneous transhepatic esophageal phlebography. Gastrointest Radiol (1979) 0.75
Total fasting serum bile acids and beta-hexosaminidase in alcoholic liver disease. Clin Chim Acta (1984) 0.75
Total serum bile acids, gamma-glutamyl transferase, prealbumin, and tyrosine: sensitive serum markers of hepatic dysfunction in alcoholic liver cirrhosis. Scand J Gastroenterol (1983) 0.75
Influence of ethanol on the human serum level of beta-hexosaminidase. Enzyme (1985) 0.75
[Transoesophageal sclerosing of bleeding oesophageal varices]. Lakartidningen (1980) 0.75
Pattern of serum beta-hexosaminidase in liver cirrhosis. Scand J Gastroenterol (1983) 0.75